Literature DB >> 28779397

Comparison between MRI with MR cholangiopancreatography and endoscopic ultrasonography for differentiating malignant from benign mucinous neoplasms of the pancreas.

Jiyoung Hwang1, Young Kon Kim2, Ji Hye Min3, Woo Kyung Jeong4, Seong Sook Hong1, Hyun-Joo Kim1.   

Abstract

OBJECTIVE: To compare diagnostic performance of magnetic resonance imaging (MRI) and endoscopic ultrasonography (EUS) for differentiating malignant from benign intraductal papillary mucinous neoplasms (IPMN) and mucinous cystic neoplasms (MCN) of the pancreas.
METHODS: This retrospective study included 55 patients with 47 surgically confirmed IPMNs (12 malignant, 35 benign) and eight MCNs (two malignant, six benign) who underwent contrast-enhanced pancreas MRI and EUS. Contrast enhancement was not routinely used at EUS examination. Two observers independently evaluated the MRIs, and another reviewed EUS images. They recorded their confidence for malignancy with each imaging modality. We calculated diagnostic performance using the area under the receiver operating characteristic curves (A z ), and to determine the accuracy, sensitivity, specificity, and positive (PPV) and negative predictive (NPV) values.
RESULTS: The A z values of MRI were higher than those of EUS (0.712 and 0.688 for MRI vs. 0.543 for EUS; p = 0.007). The diagnostic accuracies (74.5%), specificity (78.0% and 80.5%) and PPV (50.0%) of MRI in two observers were higher than those (56.4%, 58.5% and 29.2%, respectively) of EUS (p = 0.013-0.049).
CONCLUSION: MRI showed better diagnostic performance than EUS for differentiating malignant from benign pancreatic IPMN and MCN. KEY POINTS: • The A z values of MRI were higher than those of EUS. • The diagnostic accuracies of MRI were higher than those of EUS. • The specificities of MRI were higher than those of EUS.

Entities:  

Keywords:  Endoscopic ultrasonography; Intraductal papillary mucinous neoplasm; Magnetic resonance imaging; Mucinous cystic neoplasm; Mural nodule

Mesh:

Year:  2017        PMID: 28779397     DOI: 10.1007/s00330-017-4926-5

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  30 in total

1.  Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography.

Authors:  Hyo-Jin Kang; Jeong Min Lee; Ijin Joo; Bo Yun Hur; Ju Hyeon Jeon; Jin-Young Jang; Kyoungbun Lee; Ji Kon Ryu; Joon Koo Han; Byung Ihn Choi
Journal:  Radiology       Date:  2015-10-30       Impact factor: 11.105

2.  Validation of the 2012 International Consensus Guidelines Using Computed Tomography and Magnetic Resonance Imaging: Branch Duct and Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Nieun Seo; Jae Ho Byun; Jin Hee Kim; Hyoung Jung Kim; Seung Soo Lee; Ki Byung Song; Song-Cheol Kim; Duck Jong Han; Seung-Mo Hong; Moon-Gyu Lee
Journal:  Ann Surg       Date:  2016-03       Impact factor: 12.969

3.  Comparison of MRI and endoscopic ultrasound in the characterization of pancreatic cystic lesions.

Authors:  Young Chul Kim; Jin-Young Choi; Yong Eun Chung; Seungmin Bang; Myeong-Jin Kim; Mi-Suk Park; Ki Whang Kim
Journal:  AJR Am J Roentgenol       Date:  2010-10       Impact factor: 3.959

4.  Diagnostic performance of MRI and EUS in the differentiation of benign from malignant pancreatic cyst and cyst communication with the main duct.

Authors:  Jung Hoon Kim; Hyo Won Eun; Hyun-Jeong Park; Seong Sook Hong; Young Jae Kim
Journal:  Eur J Radiol       Date:  2012-01-05       Impact factor: 3.528

Review 5.  An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Authors:  Ralph H Hruban; Kyoichi Takaori; David S Klimstra; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Sandra A Biankin; Carolyn Compton; Noriyoshi Fukushima; Toru Furukawa; Michael Goggins; Yo Kato; Gunter Klöppel; Daniel S Longnecker; Jutta Lüttges; Anirban Maitra; G Johan A Offerhaus; Michio Shimizu; Suguru Yonezawa
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

6.  Prediction of malignancy with endoscopic ultrasonography in patients with branch duct-type intraductal papillary mucinous neoplasm.

Authors:  Kwang Hyuck Lee; Se-Joon Lee; Jong Kyun Lee; Ji Kon Ryu; Eun Young Kim; Tae Hyeon Kim; Jong Ho Moon; Woo Jin Lee; Yu Kyung Cho; Jae J Kim
Journal:  Pancreas       Date:  2014-11       Impact factor: 3.327

7.  Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.

Authors:  Koji Tamura; Takao Ohtsuka; Noboru Ideno; Teppei Aso; Koji Shindo; Shinichi Aishima; Kenoki Ohuchida; Shunichi Takahata; Yasuhiro Ushijima; Tetsuhide Ito; Yoshinao Oda; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Ann Surg       Date:  2014-02       Impact factor: 12.969

8.  Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT.

Authors:  Hiroshi Ogawa; Shigeki Itoh; Mitsuru Ikeda; Kojiro Suzuki; Shinji Naganawa
Journal:  Radiology       Date:  2008-07-15       Impact factor: 11.105

9.  Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms.

Authors:  J Y Jang; T Park; S Lee; M J Kang; S Y Lee; K B Lee; Y R Chang; S W Kim
Journal:  Br J Surg       Date:  2014-03-25       Impact factor: 6.939

10.  Malignant intraductal papillary mucinous neoplasm of the pancreas: in situ versus invasive carcinoma surgical resectability.

Authors:  Marie-Pierre Vullierme; Marie Giraud-Cohen; Pascal Hammel; Alain Sauvanet; Anne Couvelard; Dermot O'Toole; Philippe Levy; Philippe Ruszniewski; Valérie Vilgrain
Journal:  Radiology       Date:  2007-09-11       Impact factor: 11.105

View more
  5 in total

1.  Prognosis of resected intraductal papillary mucinous neoplasm of the pancreas: using revised 2017 international consensus guidelines.

Authors:  Ji Hye Min; Young Kon Kim; Honsoul Kim; Dong Lk Cha; Soohyun Ahn
Journal:  Abdom Radiol (NY)       Date:  2020-06-24

Review 2.  Narrative review of intraductal papillary mucinous neoplasms: pathogenesis, diagnosis, and treatment of a true precancerous lesion.

Authors:  Gang Ma; Guichen Li; Zhihuan Xiao; Anjiang Gou; Yuanhong Xu; Shaowei Song; Kejian Guo; Zhe Liu
Journal:  Gland Surg       Date:  2021-07

Review 3.  Management Algorithm for Cystic Pancreatic Lesions.

Authors:  Georg Beyer; Elisabetta Goni; Marlies Köpke; Jan G D'Haese; Jens Werner; Jörg Schirra; Julia Mayerle
Journal:  Visc Med       Date:  2018-06-13

4.  European evidence-based guidelines on pancreatic cystic neoplasms.

Authors: 
Journal:  Gut       Date:  2018-03-24       Impact factor: 23.059

5.  A new needle-based confocal laser endomicroscopy pattern of malignant pancreatic mucinous cystic lesions (with video).

Authors:  Yunlu Feng; Xiaoyan Chang; Yu Zhao; Dong Wu; Zhilan Meng; Xi Wu; Tao Guo; Qingwei Jiang; Shengyu Zhang; Qiang Wang; Aiming Yang
Journal:  Endosc Ultrasound       Date:  2021 May-Jun       Impact factor: 5.628

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.